Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Rhythm Biosciences Ltd. ( (AU:RHY) ) just unveiled an update.
Rhythm Biosciences Limited has announced a proposed issuance of up to 1,000,000 fully paid ordinary securities, with a scheduled issue date of January 30, 2026. This strategic move could provide the company with additional capital to support its ongoing development efforts and strengthen its positioning in the competitive biotechnology industry.
The most recent analyst rating on (AU:RHY) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Rhythm Biosciences Ltd. stock, see the AU:RHY Stock Forecast page.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Limited operates within the biotechnology sector, focusing on the development of diagnostic technologies for the detection of diseases, particularly cancer. Their primary products target accurate and timely disease detection, positioning them as a contributor to advancements in early medical diagnostics.
Average Trading Volume: 480,938
Technical Sentiment Signal: Sell
Current Market Cap: A$28.65M
Find detailed analytics on RHY stock on TipRanks’ Stock Analysis page.